Hyundai Motor India & IIT Madras launch ‘Hyundai Hope for Cancer’.
Hyundai Motor India Foundation (HMIF), the CSR arm of Hyundai Motor India Limited (HMIL), in collaboration with IIT Madras, launched ‘Hyundai Hope for Cancer’ - a pioneering initiative dedicated to transforming paediatric cancer care in India. As part of its multi-year commitment towards this cause, HMIF has allocated a social impact investment of INR 56 Crore towards this landmark project. At the heart of this initiative is the Hyundai Centre for Cancer Genomics, housed at IIT Madras’ main campus in Chennai.
The Centre, unveiled by Shri. Dharmendra Pradhan, Hon’ble Minister of Education - Government of India, features India’s first community-based Cancer Tissue Biobank, enabling advanced genomic research in paediatric leukaemia and lymphoma.
The Centre will focus on genomic sequencing to identify genetic mutations, laying the foundation for a national paediatric cancer genome database and personalized treatment protocols. It will also serve as a collaborative hub for clinicians, researchers, pharmaceutical scientists, and global partners, contributing to international efforts such as the International Cancer Genome Consortium (ICGC) and WHO’s International Agency for Research on Cancer (IARC).
Chennai Press News
Hyundai Motor India & IIT Madras launch ‘Hyundai Hope for Cancer’.
Hyundai Motor India Foundation (HMIF), the CSR arm of Hyundai Motor India Limited (HMIL), in collaboration with IIT Madras, launched ‘Hyundai Hope for Cancer’ - a pioneering initiative dedicated to transforming paediatric cancer care in India. As part of its multi-year commitment towards this cause, HMIF has allocated a social impact investment of INR 56 Crore towards this landmark project. At the heart of this initiative is the Hyundai Centre for Cancer Genomics, housed at IIT Madras’ main campus in Chennai.
The Centre, unveiled by Shri. Dharmendra Pradhan, Hon’ble Minister of Education - Government of India, features India’s first community-based Cancer Tissue Biobank, enabling advanced genomic research in paediatric leukaemia and lymphoma.
The Centre will focus on genomic sequencing to identify genetic mutations, laying the foundation for a national paediatric cancer genome database and personalized treatment protocols. It will also serve as a collaborative hub for clinicians, researchers, pharmaceutical scientists, and global partners, contributing to international efforts such as the International Cancer Genome Consortium (ICGC) and WHO’s International Agency for Research on Cancer (IARC).
6 hours ago | [YT] | 0